Drugs / BMS-986104
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02211469 | Aug 2014 → Jul 2015 | rheumatoid arthritis | Bristol-Myers Squibb | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BMS-986104 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02211469 ↗ |
| Modality | Small molecule | — CHEMBL3806158 ↗ |
| Route | Oral | “BMS-986104 or Placebo single dose by mouth as specified” NCT02211469 ↗ |